In another investigation, no significant correlation was identified between p53 codon 72 polymorphism and clinical parameters (gender, cytogenetic risk, FAB subtype, etc.)in Chinese patients with AML [322]. This evidence concerns the gene TP53 and acute myeloid leukemia.